Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-052780
Filing Date
2021-08-20
Accepted
2021-08-20 16:30:24
Documents
1
Period of Report
2021-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5854
  Complete submission text file 0001209191-21-052780.txt   7274
Mailing Address C/O HIGHBRIDGE CAPITAL MANAGEMENT, LLC 40 WEST 57TH STREET, 32ND FLOOR NEW YORK NY 10019
Business Address
Dubin Glenn (Reporting) CIK: 0001308597 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 211194214

Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)